Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC6A2 | P23975 | 3/20 | 0.44 |
| ▸ | SLC6A4 | P31645 | 3/20 | 0.44 |
| ▸ | SLC6A3 | Q01959 | 3/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.42 |
| ▸ | ATM | Q13315 | 1/20 | 0.42 |
| ▸ | CFTR | P13569 | 1/20 | 0.40 |
| ▸ | GOPC | Q9HD26 | 1/20 | 0.40 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.35 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.35 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.35 |
| ▸ | DPP4 | P27487 | 2/20 | 0.35 |
| ▸ | F2 | P00734 | 1/20 | 0.35 |
| ▸ | TSHR | P16473 | 1/20 | 0.35 |
| ▸ | CES2 | O00748 | 1/20 | 0.33 |
| ▸ | CES1 | P23141 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5865581 | 0.95 | KMT2A (0.47) | SLC6A2SLC6A4SLC6A3KMT2AATM | |
| SCHEMBL16270678 | 0.92 | SLC6A2 (0.39) | SLC6A2SLC6A4SLC6A3KMT2AATM | |
| SCHEMBL24671964 | 0.92 | SLC6A2 (0.39) | SLC6A2SLC6A4SLC6A3KMT2AATM | |
| SCHEMBL14322127 | 0.90 | SLC6A2 (0.32) | SLC6A2SLC6A4SLC6A3KMT2AATM | |
| SCHEMBL17904266 | 0.87 | CHRNB2 (0.39) | SLC6A2SLC6A4SLC6A3KMT2AATM | |
| SCHEMBL10526789 | 0.86 | CHRNB2 (0.42) | SLC6A2SLC6A4SLC6A3KMT2AATM | |
| SCHEMBL19633944 | 0.84 | SLC6A2 (0.33) | SLC6A2SLC6A4SLC6A3KMT2AATM | |
| SCHEMBL1345605 | 0.82 | DAO (0.35) | HDAC8HDAC6 | |
| SCHEMBL19633885 | 0.80 | ESR1 (0.38) | SLC6A2SLC6A3KMT2AHDAC8HDAC6 | |
| SCHEMBL440120 | 0.80 | HTR2A (0.35) | KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 76 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114920751-B | Three-center metal complex and application thereof | 齐齐哈尔大学 | 2022-12-13 | — | — | CN | claimed |
| CN-103003282-B | A kind of prepare new derivatives of porphyrin method and purposes as PDT reagent and fluorescent probe | COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) | 2016-01-20 | — | — | CN | claimed |
| CN-103003282-A | A process for the preparation of novel porphyrin derivatives and their use as PDT agents and fluorescence probes | COUNCIL SCIENT IND RES | 2013-03-27 | — | — | CN | claimed |
| CN-118878853-A | Synthesis method and application of porphyrin metal organic framework-based nanomaterial catalyst | 安阳工学院 | 2024-11-01 | — | — | CN | disclosed |
| US-20230287008-A1 | COMPOUND AND OPTICAL FILM COMPRISING SAME | LG CHEM, LTD. (KR) | 2023-09-14 | — | — | US | disclosed |
| US-20230051807-A1 | PORPHYRIN PHOTOSENSITIZER AND COBALOXIME COCATALYST AND METHODS OF USE THEREOF | THE HONG KONG POLYTECHNIC UNIVERSITY (CN) | 2023-02-16 | — | — | US | disclosed |
| US-20220403136-A1 | OPTICAL FILM FORMING COMPOSITION, OPTICAL FILM, AND DISPLAY DEVICE INCLUDING SAME | LG CHEM, LTD. (KR) | 2022-12-22 | — | — | US | disclosed |
| CN-114920751-B | Three-center metal complex and application thereof | 齐齐哈尔大学 | 2022-12-13 | — | — | CN | disclosed |
| US-20210088526-A1 | FLUORESCENT COMPOUND AND FLUORESCENT LABELED BIOLOGICAL SUBSTANCE USING THE SAME | FUJIFILM CORPORATION (JP) | 2021-03-25 | — | — | US | disclosed |
| EP-3612538-B1 | QUINONE-METHIDE PRECURSORS WITH BODIPY CHROMOPHORE, METHOD OF PREPARATION, BIOLOGICAL ACTIVITY AND APPLICATION IN FLUORESCENT LABELLING | RUDJER BOSKOVIC INST (HR) | 2021-01-13 | — | — | EP | disclosed |
| US-20200197423-A1 | Quinone-methide precursors with bodipy chromophore, method of preparation, biological activity and application in fluorescent labelling | RUDJER BOSKOVIC INSTITUTE (HR) | 2020-06-25 | — | — | US | disclosed |
| US-7317108-B2 | Boron complexation strategy for use in manipulating 1-acyldipyrromethanes | NORTH CAROLINA STATE UNIVERSITY (US) | 2008-01-08 | — | — | US | disclosed |
| US-7317108-B2 | Boron complexation strategy for use in manipulating 1-acyldipyrromethanes | NORTH CAROLINA STATE UNIVERSITY (US) | 2008-01-08 | — | — | US | disclosed |
| US-7282582-B2 | Boron complexation strategy for use in manipulating 1-acyldipyrromethanes | NORTH CAROLINA STATE UNIVERSITY (US) | 2007-10-16 | — | — | US | disclosed |
| US-7282582-B2 | Boron complexation strategy for use in manipulating 1-acyldipyrromethanes | NORTH CAROLINA STATE UNIVERSITY (US) | 2007-10-16 | — | — | US | disclosed |
| US-20070088158-A1 | BORON COMPLEXATION STRATEGY FOR USE IN MANIPULATING 1-ACYLDIPYRROMETHANES | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2007-04-19 | — | — | US | disclosed |
| US-20070088158-A1 | BORON COMPLEXATION STRATEGY FOR USE IN MANIPULATING 1-ACYLDIPYRROMETHANES | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2007-04-19 | — | — | US | disclosed |
| WO-2007018807-A2 | METHODS AND INTERMEDIATES FOR THE SYNTHESIS OF PORPHYRINS | NORTH CAROLINA STATE UNIVERSITY (US) | 2007-02-15 | — | — | WO | disclosed |
| US-20070027311-A1 | Methods and intermediates for the synthesis of porphyrins | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2007-02-01 | — | — | US | disclosed |
| US-20070027311-A1 | Methods and intermediates for the synthesis of porphyrins | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2007-02-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230051807-A1 | PORPHYRIN PHOTOSENSITIZER AND COBALOXIME COCATALYST AND METHODS OF USE THEREOF | PPOX, HMBS, PNPO | SLC6A2 2539/4885SLC6A4 1224/4885SLC6A3 1324/4885 |
| US-20070088158-A1 | BORON COMPLEXATION STRATEGY FOR USE IN MANIPULATING 1-ACYLDIPYRROMETHANES | DECR2, ANTXR2, CD79B | SLC6A2 3440/4885SLC6A4 4073/4885SLC6A3 2300/4885 |
| US-20220403136-A1 | OPTICAL FILM FORMING COMPOSITION, OPTICAL FILM, AND DISPLAY DEVICE INCLUDING SAME | CDH1, CFL1, ITGA1 | SLC6A2 3368/4885SLC6A4 3607/4885SLC6A3 3128/4885 |
| US-20230287008-A1 | COMPOUND AND OPTICAL FILM COMPRISING SAME | CDH1, OR10J3, CRY1 | SLC6A2 3686/4885SLC6A4 3424/4885SLC6A3 3291/4885 |
| US-20070027311-A1 | Methods and intermediates for the synthesis of porphyrins | PPOX, HMBS, CYC1 | SLC6A2 4161/4885SLC6A4 4433/4885SLC6A3 3890/4885 |
| US-20200197423-A1 | Quinone-methide precursors with bodipy chromophore, method of preparation, biological activity and application in fluorescent labelling | NQO2, NQO1, CYBA | SLC6A2 3225/4885SLC6A4 4352/4885SLC6A3 3597/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.